FDA Inspection 1269231 — Annora Pharma Private Limited
The FDA completed an inspection of Annora Pharma Private Limited on Mar 13, 2025 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 13, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional details
Bioanalytical BA/BE